Chargement en cours...

OnabotulinumtoxinA for chronic migraine: a critical appraisal

Chronic migraine (CM) is a severe disabling condition with a few available evidence-based management options. OnabotulinumtoxinA (onaBoNTA) is approved for use in a number of disorders. Its benefits and potential use in migraine were observed incidentally while treating patients cosmetically for wri...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ther Clin Risk Manag
Auteurs principaux: Gooriah, Rubesh, Ahmed, Fayyaz
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4492656/
https://ncbi.nlm.nih.gov/pubmed/26170679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S76964
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!